| Share-based compensation |
Note 9 — Share-based compensation
The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
|
|
September 30, |
|
September 30, |
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
|
Research and development |
|
$ |
1,219 |
|
$ |
144 |
|
$ |
3,126 |
|
$ |
2,951 |
|
|
General and administrative |
|
|
2,061 |
|
|
1,676 |
|
|
4,226 |
|
|
5,544 |
|
|
|
|
$ |
3,280 |
|
$ |
1,820 |
|
$ |
7,352 |
|
$ |
8,495 |
|
|
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
|
|
|
September 30, |
|
September 30, |
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
Number of options over ordinary shares granted |
|
|
1,882,966 |
|
|
3,733,359 |
|
|
14,851,182 |
|
|
15,477,255 |
|
Weighted average fair value of ordinary shares options |
|
$ |
1.25 |
|
$ |
0.31 |
|
$ |
0.57 |
|
$ |
0.48 |
|
Number of additional options with a nominal exercise price granted |
|
|
571,320 |
|
|
743,292 |
|
|
7,410,136 |
|
|
7,700,658 |
|
Weighted average fair value of options with a nominal exercise price |
|
$ |
1.70 |
|
|
0.51 |
|
$ |
0.78 |
|
$ |
0.89 |
|
|